NeuroVive Pharmaceutical AB SMA 200
¿Qué es el SMA 200 de NeuroVive Pharmaceutical AB?
El SMA 200 de NeuroVive Pharmaceutical AB es kr0 +6.37%
¿Cuál es la definición de SMA 200?
SMA 200 es un precio promedio de las acciones de los últimos 200 días calculado como una media no ponderada de los previos 200 precios de cierre de acciones.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 de compañías en Sector Miscellaneous en LSE en comparadas con NeuroVive Pharmaceutical AB
¿Qué hace NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas con sma 200 similar a NeuroVive Pharmaceutical AB
- Silver Dollar Resources Inc tiene SMA 200 de $0 -17.67%
- Sheng Yuan tiene SMA 200 de HKD$0 -11.64%
- Tsodilo Resources tiene SMA 200 de CAD$0 -95.37%
- Argo International tiene SMA 200 de $0 -30.36%
- Stampede Drilling tiene SMA 200 de CAD$0 -11.74%
- Stealth Global tiene SMA 200 de AUD$0 +32.96%
- NeuroVive Pharmaceutical AB tiene SMA 200 de kr0 +6.37%
- GORE German Office Real Estate AG tiene SMA 200 de €0 -209.45%
- Gemini Investments () tiene SMA 200 de HKD$0 +1.88%
- Wisdom Education International tiene SMA 200 de HKD$0 -59.19%
- Avant Brands Inc tiene SMA 200 de CAD$0 +79.69%
- Element 25 tiene SMA 200 de AUD$0 -20.91%
- BCI Minerals tiene SMA 200 de AUD$0 +11.02%